Software and biotech patent reform
A report for the U.S. Congress takes on the problems present in software and biotechnology patents, and makes some recommendations for reform. The report concludes: The multiplicity of patents involved in computer-related products has resulted in the extensive use of cross licensing in these industries such that one commentator argues: Read more…